Degang Ding
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Surgery 11
- Bladder and Urothelial Cancer Treatments 6
- Urinary and Genital Oncology Studies 4
-
- Circular RNAs in diseases 2
- Co-authors
- Tao Du (4 shared papers)Zhaoqiang Jiang (1 shared paper)Jianjun Liu (1 shared paper)Jie Liu (1 shared paper)Xing Li (3 shared papers)Zhonghua Liu (3 shared papers)Xiangsheng Zhang (4 shared papers)Lei Shan (1 shared paper)
- Journals
- Medicine (2 papers)Journal of Clinical Hypertension (2 papers)BMJ Open (1 paper)Human Cell (1 paper)Cancer Biology and Medicine (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Degang Ding
25 papers receiving 317 citations
Peers
Comparison fields: 5 of 64
- Cancer Research 110
- Urology 17
- Molecular Biology 176
- Pulmonary and Respiratory Medicine 62
- Immunology 37
Countries citing papers authored by Degang Ding
This map shows the geographic impact of Degang Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Degang Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Degang Ding more than expected).
Fields of papers citing papers by Degang Ding
This network shows the impact of papers produced by Degang Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Degang Ding. The network helps show where Degang Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Degang Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 59 | |
| 2 | 2020 | 44 | |
| 3 | 2014 | 32 | |
| 4 | 2019 | 28 | |
| 5 | 2019 | 18 | |
| 6 | 2020 | 17 | |
| 7 | 2021 | 15 | |
| 8 | 2021 | 15 | |
| 9 | 2000 | 12 | |
| 10 | 2013 | 11 | |
| 11 | 2022 | 10 | |
| 12 | 2019 | 10 | |
| 13 | 2017 | 9 | |
| 14 | 2021 | 9 | |
| 15 | 2019 | 7 | |
| 16 | 2021 | 5 | |
| 17 | 2023 | 4 | |
| 18 | 2020 | 4 | |
| 19 | [The effect of cell killing by ABT-737 synergized with docetaxel in human prostate cancer PC-3 cells]. | 2012 | 3 |
| 20 | 2017 | 2 |
About Degang Ding
Degang Ding is a scholar working on Surgery, Molecular Biology, Pulmonary and Respiratory Medicine, Urology and Oncology, having authored 28 papers that have together received 319 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (6 papers), Urinary and Genital Oncology Studies (4 papers), MicroRNA in disease regulation (3 papers), Hormonal Regulation and Hypertension (3 papers), Urological Disorders and Treatments (3 papers), Renal cell carcinoma treatment (3 papers), Blood Pressure and Hypertension Studies (3 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (110 citations), Urology (17 citations), Molecular Biology (176 citations), Pulmonary and Respiratory Medicine (62 citations) and Immunology (37 citations). Degang Ding has collaborated with scholars based in China and United States. Frequent co-authors include Tao Du, Zhaoqiang Jiang, Jianjun Liu, Jie Liu, Xing Li, Zhonghua Liu, Xiangsheng Zhang, Lei Shan, Xiaoli Zhang and Shilong Zhang. Their work appears in journals such as Medicine, Journal of Clinical Hypertension, BMJ Open, Human Cell and Cancer Biology and Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.